Allianz Asset Management Gmb H Aclaris Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

  • $69.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
SELL
$13.07 - $18.22 $1.02 Million - $1.42 Million
-78,030 Reduced 78.16%
21,800 $343,000
Q2 2022

Aug 12, 2022
BUY
$10.16 - $17.08 $181,508 - $305,134
17,865 Added 21.8%
99,830 $1.39 Million
Q1 2022

May 13, 2022
BUY
$9.74 - $17.92 $244,717 - $450,240
25,125 Added 44.2%
81,965 $1.41 Million
Q3 2021

Nov 10, 2021
BUY
$13.38 - $18.8 $760,519 - $1.07 Million
56,840 New
56,840 $1.02 Million

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email